RU2002113652A - Гормональная композиция на основе гестагена и эстрогена и ее применение - Google Patents
Гормональная композиция на основе гестагена и эстрогена и ее применениеInfo
- Publication number
- RU2002113652A RU2002113652A RU2002113652/15A RU2002113652A RU2002113652A RU 2002113652 A RU2002113652 A RU 2002113652A RU 2002113652/15 A RU2002113652/15 A RU 2002113652/15A RU 2002113652 A RU2002113652 A RU 2002113652A RU 2002113652 A RU2002113652 A RU 2002113652A
- Authority
- RU
- Russia
- Prior art keywords
- estrogen
- progestogen
- estradiol
- compositions
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Claims (12)
1. Фармацевтические гормональные композиции для лечения эстрогенной недостаточности и предупреждения остеопороза и сердечно-сосудистых заболеваний у женщин в период менопаузы, отличающиеся тем, что они образованы эстро-гестагенной комбинацией, предназначенной для перорального введения, содержащей эстрогенный компонент в дозе от 0,3 до 3 мг и гестагенный компонент, выбираемый из номегестрола и одного из его сложных эфиров, в дозе от 0,3 до 1,5 мг, в сочетании или в смеси с одним или несколькими нетоксичными, инертными фармацевтически приемлемыми носителями.
2. Эстро-гестагенные композиции по п.1, в которых эстроген выбирают из свободного или этерифицированного 17β-эстрадиола и коньюгированных конских эстрогенов.
3. Эстро-гестагенные композиции по п.2, в которых эстрогеном является 17β-эстрадиол.
4. Эстро-гестагенные композиции по п.2, в которых эстрогеном является сложный эфир эстрадиола, в частности валерат эстрадиола.
5. Эстро-гестагенные композиции по п.2, в которых эстроген представляет собой коньюгированный конский эстроген.
6. Эстро-гестагенные композиции по п.3, в которых свободный эстрадиол содержится в разовой дозе в количестве от 0,5 до 1,5 мг.
7. Эстро-гестагенные композиции по п.4, в которых сложный эфир эстрадиола содержится в разовой дозе в количестве от 1,5 до 2 мг.
8. Эстро-гестагенные композиции по п.5, в которых коньюгированный конский эстроген содержится в разовой дозе в количестве от 0,312 до 0,625 мг.
9. Эстро-гестагенные композиции по пп.1-8, в которых гестагеном является ацетат номегестрола.
10. Эстро-гестагенные композиции по п.9, в которых ацетат номегестрола содержится в разовой дозе в количестве от 0,625 до 1,25 мг.
11. Эстро-гестагенные композиции по одному из пп.1-10, предназначенные для введения непрерывно или периодически.
12. Способ получения новых эстро-гестагенных композиций по одному из пп.1-11, в котором эстрогенное активное начало и гестагенное активное начало смешивают с или вводят в один или несколько инертных, нетоксичных фармацевтически приемлемых наполнителей.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/FR1999/002588 WO2001030356A1 (fr) | 1999-10-25 | 1999-10-25 | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
| FRPCT/FR99/02588 | 1999-10-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2002113652A true RU2002113652A (ru) | 2004-03-27 |
| RU2261106C2 RU2261106C2 (ru) | 2005-09-27 |
Family
ID=9542727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2002113652/15A RU2261106C2 (ru) | 1999-10-25 | 2000-10-24 | Гормональная композиция на основе гестагена и эстрогена и ее применение |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US8168619B1 (ru) |
| EP (1) | EP1227814B1 (ru) |
| JP (1) | JP5036943B2 (ru) |
| KR (1) | KR100623788B1 (ru) |
| CN (1) | CN100553637C (ru) |
| AP (1) | AP1625A (ru) |
| AT (1) | ATE286400T1 (ru) |
| AU (1) | AU777704B2 (ru) |
| BR (1) | BRPI0014979B8 (ru) |
| CA (1) | CA2389025C (ru) |
| CZ (1) | CZ303248B6 (ru) |
| DE (1) | DE60017281T2 (ru) |
| DK (1) | DK1227814T3 (ru) |
| ES (1) | ES2235967T3 (ru) |
| HK (1) | HK1050472B (ru) |
| HU (1) | HU229382B1 (ru) |
| IL (2) | IL148953A0 (ru) |
| MX (1) | MXPA02004084A (ru) |
| NO (1) | NO327973B1 (ru) |
| NZ (1) | NZ518145A (ru) |
| OA (1) | OA12072A (ru) |
| PL (1) | PL199848B1 (ru) |
| PT (1) | PT1227814E (ru) |
| RU (1) | RU2261106C2 (ru) |
| SI (1) | SI1227814T1 (ru) |
| WO (2) | WO2001030356A1 (ru) |
| ZA (1) | ZA200203398B (ru) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
| WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
| FR2814074B1 (fr) * | 2000-09-15 | 2003-03-07 | Theramex | Nouvelles compositions estro-progestatives topiques a effet systemique |
| CA2447178C (en) | 2001-05-18 | 2010-06-08 | Christian Franz Holinka | Pharmaceutical composition for use in hormone replacement therapy |
| US7732430B2 (en) | 2001-05-23 | 2010-06-08 | Pantarhei Bioscience B.V. | Drug delivery system comprising a tetrahydroxilated estrogen for use in hormonal contraception |
| DE60234515D1 (de) | 2001-05-23 | 2010-01-07 | Pantarhei Bioscience Bv | Tetrahydroxylierte estrogen enthaltendes arzneistoffverabreichungssystem zur verwendung in hormonalen kontrazeption |
| CA2467222C (en) | 2001-11-15 | 2010-06-08 | Herman Jan Tijmen Coelingh Bennink | Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy |
| SI1511496T1 (sl) | 2002-06-11 | 2007-04-30 | Pantarhei Bioscience Bv | Metoda zdravljenja ali prevencije imunsko mediiranih motenj in farmacevtska formulacija za njeno uporabo |
| US7943604B2 (en) | 2002-06-11 | 2011-05-17 | Pantarhei Bioscience B.V. | Method of treating human skin and a skin care composition for use in such a method |
| EP1515725A4 (en) * | 2002-06-25 | 2005-09-21 | Wyeth Corp | USE OF CYCLOTHIOCARBAMATE DERIVATIVES IN THE TREATMENT OF HORMONE-RELATED ILLNESSES |
| AU2003253506A1 (en) | 2002-07-12 | 2004-02-02 | Pantarhei Biosciences B.V. | Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy |
| AU2003274823A1 (en) | 2002-10-23 | 2004-05-13 | Pantarhei Bioscience B.V. | Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy |
| ATE473746T1 (de) | 2007-01-08 | 2010-07-15 | Pantarhei Bioscience Bv | Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens |
| CN107007611B (zh) * | 2017-06-02 | 2020-04-14 | 上海市计划生育科学研究所 | 醋酸诺美孕酮在制备治疗子宫内膜癌的药物中的应用 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| JPS61243059A (ja) | 1985-04-19 | 1986-10-29 | Konishi Kagaku Kogyo Kk | 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法 |
| DE3603644A1 (de) | 1986-02-06 | 1987-08-13 | Metabowerke Kg | Spannfutter zum einspannen von bohrern oder schlagbohrern |
| ZA87332B (en) | 1986-02-27 | 1987-08-26 | Warner Lambert Co | Compositions containing fixed combinations |
| US5208225A (en) * | 1986-02-27 | 1993-05-04 | Warner-Lambert Company | Compositions containing fixed combinations |
| US5276022A (en) | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
| NZ226316A (en) | 1987-09-24 | 1991-10-25 | Jencap Research Ltd | Pharmaceutical contraceptive preparations and packages containing from 20-35 unit dosages comprising an estrogen and a progestin; the unit dosages having alternating estrogen and progestin dominance |
| CA1332227C (en) | 1987-09-24 | 1994-10-04 | Robert F. Casper | Oral contraceptive formulation |
| US5108995A (en) | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
| US5256421A (en) | 1987-09-24 | 1993-10-26 | Jencap Research Ltd. | Hormone preparation and method |
| HUT52382A (en) | 1988-03-14 | 1990-07-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case |
| IE71203B1 (en) | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
| FR2695826B1 (fr) | 1992-09-21 | 1995-01-06 | Theramex | Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention. |
| US5554601A (en) | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
| US5552394A (en) | 1994-07-22 | 1996-09-03 | The Medical College Of Hampton Roads | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
| US6613757B1 (en) | 1994-09-22 | 2003-09-02 | Board Of Regents, The University Of Texas System | Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| SE9403389D0 (sv) | 1994-10-06 | 1994-10-06 | Astra Ab | Pharmaceutical composition containing derivattves of sex hormones |
| CA2227989A1 (en) | 1995-08-01 | 1997-02-13 | Karen Ophelia Hamilton | Liposomal oligonucleotide compositions |
| FR2737411B1 (fr) | 1995-08-01 | 1997-10-17 | Theramex | Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques |
| US5888543A (en) | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
| WO2001030355A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
| FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
| DE19739916C2 (de) | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
| FR2776191B1 (fr) * | 1998-03-23 | 2002-05-31 | Theramex | Composition hormonale topique a effet systemique |
| WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
| FR2814074B1 (fr) * | 2000-09-15 | 2003-03-07 | Theramex | Nouvelles compositions estro-progestatives topiques a effet systemique |
| EP1443966B1 (en) * | 2001-11-15 | 2007-03-14 | Pantarhei Bioscience B.V. | Method of preventing or treating benign gynaecological disorders |
| AR065816A1 (es) | 2007-03-26 | 2009-07-01 | Theramex | Regimen anticonceptivo oral |
-
1999
- 1999-10-25 WO PCT/FR1999/002588 patent/WO2001030356A1/fr active Application Filing
- 1999-10-29 US US09/423,109 patent/US8168619B1/en not_active Expired - Fee Related
-
2000
- 2000-10-24 ES ES00971476T patent/ES2235967T3/es not_active Expired - Lifetime
- 2000-10-24 AT AT00971476T patent/ATE286400T1/de active
- 2000-10-24 NZ NZ518145A patent/NZ518145A/en not_active IP Right Cessation
- 2000-10-24 CA CA002389025A patent/CA2389025C/fr not_active Expired - Lifetime
- 2000-10-24 CZ CZ20021427A patent/CZ303248B6/cs not_active IP Right Cessation
- 2000-10-24 OA OA1200200119A patent/OA12072A/fr unknown
- 2000-10-24 RU RU2002113652/15A patent/RU2261106C2/ru not_active IP Right Cessation
- 2000-10-24 WO PCT/FR2000/002939 patent/WO2001030357A1/fr active IP Right Grant
- 2000-10-24 AP APAP/P/2002/002475A patent/AP1625A/en active
- 2000-10-24 PL PL356847A patent/PL199848B1/pl unknown
- 2000-10-24 JP JP2001532775A patent/JP5036943B2/ja not_active Expired - Fee Related
- 2000-10-24 KR KR1020027005259A patent/KR100623788B1/ko active IP Right Grant
- 2000-10-24 DE DE60017281T patent/DE60017281T2/de not_active Expired - Lifetime
- 2000-10-24 DK DK00971476T patent/DK1227814T3/da active
- 2000-10-24 AU AU10326/01A patent/AU777704B2/en not_active Ceased
- 2000-10-24 HU HU0203721A patent/HU229382B1/hu not_active IP Right Cessation
- 2000-10-24 CN CNB008147841A patent/CN100553637C/zh not_active Expired - Fee Related
- 2000-10-24 PT PT00971476T patent/PT1227814E/pt unknown
- 2000-10-24 BR BRPI0014979A patent/BRPI0014979B8/pt not_active IP Right Cessation
- 2000-10-24 EP EP00971476A patent/EP1227814B1/fr not_active Expired - Lifetime
- 2000-10-24 MX MXPA02004084A patent/MXPA02004084A/es active IP Right Grant
- 2000-10-24 IL IL14895300A patent/IL148953A0/xx active IP Right Grant
- 2000-10-24 SI SI200030615T patent/SI1227814T1/xx unknown
-
2002
- 2002-04-01 IL IL148953A patent/IL148953A/en unknown
- 2002-04-25 NO NO20021949A patent/NO327973B1/no not_active IP Right Cessation
- 2002-04-29 ZA ZA200203398A patent/ZA200203398B/en unknown
-
2003
- 2003-02-06 HK HK03100875.7A patent/HK1050472B/zh not_active IP Right Cessation
-
2012
- 2012-04-17 US US13/448,953 patent/US9084796B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5858405A (en) | Oral contraceptive | |
| RU2002113652A (ru) | Гормональная композиция на основе гестагена и эстрогена и ее применение | |
| US5888543A (en) | Oral contraceptives | |
| CN1186024C (zh) | 单阶段避孕方法和含有黄体酮和雌激素组合物的避孕药盒 | |
| US5747480A (en) | Oral contraceptive | |
| AR073972A2 (es) | Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas | |
| JP2007511533A (ja) | 段階的エストロゲン避妊薬 | |
| RU2003107072A (ru) | Применение гормональной композиции, содержащей сочетание эстрогена и прогестагена | |
| WO1998004246A2 (en) | Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
| AU713016B2 (en) | Oral contraceptive | |
| CN1270521A (zh) | 第一阶段包含孕激素/雌激素并且第二阶段包含孕激素的口服避孕制剂 | |
| KR20000029536A (ko) | 2상피임방법및프로제스틴과에스트로젠과의배합물을포함하는킷 | |
| AU781836B2 (en) | Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (HRT) | |
| WO1998004266A1 (en) | Oral contraceptive | |
| RU99109091A (ru) | Гормональная композиция, состоящая из эстрогенного соединения и прогестеронового соединения | |
| AU2003206424B2 (en) | Sequential estrogen/progesterone antagonist combination for hormone replacement therapy | |
| de Gaetano et al. | Cardiovascular Disease: Risk Factors Related to Thrombosis | |
| WO1997041870A1 (en) | Oral contraceptive | |
| MXPA99000883A (en) | Oral contraceptive | |
| MXPA99000801A (en) | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
| WO1997041869A1 (en) | Oral contraceptive | |
| MXPA98007513A (en) | Sequencial combination of estrogen / antagonist of progesterone for therapy of replacement of hormo | |
| JP2002541076A (ja) | 望ましくない子宮出血の処置に有用な鼻腔用医薬組成物を得るための性ホルモンの使用 | |
| WO2006036055A2 (en) | Method of female contraception and kit for use in such method | |
| MXPA99001793A (en) | Transdermal therapeutical approach involving a combination of active substances containing oestriol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20191025 |